The effect of tacrine and leupeptin on the secretion of the beta- amyloid precursor protein in HeLa cells

Debomoy Lahiri, Martin Farlow, K. Sambamurti, C. Nall

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The senile plaque in Alzheimer's disease (AD) consists mainly of the amyloid β-peptide (Aβ) derived from a larger beta-amyloid precursor protein (βAPP). The majority of BAPP is processed by either a secretory or lysosomal/ endosomal pathway. Soluble derivatives of βAPP (sAPP) and Aβ generated by the proteolytic processing of full-length βAPP are normally secreted into the conditioned medium of cultured cells. Tacrine, a centrally active potent cholinesterase inhibitor that has been shown to improve cognitive functions in some patients with AD, inhibits the secretion of sAPP. Here we have investigated whether leupeptin, a lysosomal protease inhibitor, could influence this effect of tacrine. We analyzed levels of βAPP derivatives in cultured HeLa cells by immunoblotting cell lysates and conditioned media using the monoclonal antibody 22C11. Levels of sAPP normally present in conditioned media were severely reduced by treating cells with tacrine. The treatment of cells with tacrine resulted in a small decrease in the intracellular levels of βAPP. The effect of treating the cells with tacrine did not depend upon the growing state of the cells as a similar effect was observed when the drug was added either during initial plating of the cells or after the attachment of the cells. The effect of tacrine was not affected by preincubating the cells with low serum in the culture medium. The treatment of cells with tacrine plus leupeptin reduced the secretion of sAPP in the medium to the same degree as did the treatment with tacrine alone, suggesting that the tacrine-mediated inhibition of sAPP release may not involve leupeptin-sensitive proteolytic pathways. The results suggest that the inhibitory effect of tacrine on sAPP secretion is not due to the proteolytic cleavage of the holoprotein in the medium.

Original languageEnglish
Pages (from-to)1985-1992
Number of pages8
JournalLife Sciences
Volume61
Issue number20
DOIs
StatePublished - Oct 10 1997

Fingerprint

Tacrine
Amyloid beta-Protein Precursor
HeLa Cells
Derivatives
Conditioned Culture Medium
Serum Amyloid A Protein
Cells
Cultured Cells
Alzheimer Disease
leupeptin
Cholinesterase Inhibitors
Amyloid Plaques
Staphylococcal Protein A
Protease Inhibitors
Plating
Immunoblotting
Amyloid
Cognition
Culture Media
Therapeutics

Keywords

  • Alzheimer's disease
  • Amyloid precursor proteins
  • Cholinergic agents
  • Cholinesterase inhibitors
  • Lysosomes

ASJC Scopus subject areas

  • Pharmacology

Cite this

The effect of tacrine and leupeptin on the secretion of the beta- amyloid precursor protein in HeLa cells. / Lahiri, Debomoy; Farlow, Martin; Sambamurti, K.; Nall, C.

In: Life Sciences, Vol. 61, No. 20, 10.10.1997, p. 1985-1992.

Research output: Contribution to journalArticle

@article{2cf6c064f5c340b3b50ba382229ac9dc,
title = "The effect of tacrine and leupeptin on the secretion of the beta- amyloid precursor protein in HeLa cells",
abstract = "The senile plaque in Alzheimer's disease (AD) consists mainly of the amyloid β-peptide (Aβ) derived from a larger beta-amyloid precursor protein (βAPP). The majority of BAPP is processed by either a secretory or lysosomal/ endosomal pathway. Soluble derivatives of βAPP (sAPP) and Aβ generated by the proteolytic processing of full-length βAPP are normally secreted into the conditioned medium of cultured cells. Tacrine, a centrally active potent cholinesterase inhibitor that has been shown to improve cognitive functions in some patients with AD, inhibits the secretion of sAPP. Here we have investigated whether leupeptin, a lysosomal protease inhibitor, could influence this effect of tacrine. We analyzed levels of βAPP derivatives in cultured HeLa cells by immunoblotting cell lysates and conditioned media using the monoclonal antibody 22C11. Levels of sAPP normally present in conditioned media were severely reduced by treating cells with tacrine. The treatment of cells with tacrine resulted in a small decrease in the intracellular levels of βAPP. The effect of treating the cells with tacrine did not depend upon the growing state of the cells as a similar effect was observed when the drug was added either during initial plating of the cells or after the attachment of the cells. The effect of tacrine was not affected by preincubating the cells with low serum in the culture medium. The treatment of cells with tacrine plus leupeptin reduced the secretion of sAPP in the medium to the same degree as did the treatment with tacrine alone, suggesting that the tacrine-mediated inhibition of sAPP release may not involve leupeptin-sensitive proteolytic pathways. The results suggest that the inhibitory effect of tacrine on sAPP secretion is not due to the proteolytic cleavage of the holoprotein in the medium.",
keywords = "Alzheimer's disease, Amyloid precursor proteins, Cholinergic agents, Cholinesterase inhibitors, Lysosomes",
author = "Debomoy Lahiri and Martin Farlow and K. Sambamurti and C. Nall",
year = "1997",
month = "10",
day = "10",
doi = "10.1016/S0024-3205(97)00868-0",
language = "English",
volume = "61",
pages = "1985--1992",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "20",

}

TY - JOUR

T1 - The effect of tacrine and leupeptin on the secretion of the beta- amyloid precursor protein in HeLa cells

AU - Lahiri, Debomoy

AU - Farlow, Martin

AU - Sambamurti, K.

AU - Nall, C.

PY - 1997/10/10

Y1 - 1997/10/10

N2 - The senile plaque in Alzheimer's disease (AD) consists mainly of the amyloid β-peptide (Aβ) derived from a larger beta-amyloid precursor protein (βAPP). The majority of BAPP is processed by either a secretory or lysosomal/ endosomal pathway. Soluble derivatives of βAPP (sAPP) and Aβ generated by the proteolytic processing of full-length βAPP are normally secreted into the conditioned medium of cultured cells. Tacrine, a centrally active potent cholinesterase inhibitor that has been shown to improve cognitive functions in some patients with AD, inhibits the secretion of sAPP. Here we have investigated whether leupeptin, a lysosomal protease inhibitor, could influence this effect of tacrine. We analyzed levels of βAPP derivatives in cultured HeLa cells by immunoblotting cell lysates and conditioned media using the monoclonal antibody 22C11. Levels of sAPP normally present in conditioned media were severely reduced by treating cells with tacrine. The treatment of cells with tacrine resulted in a small decrease in the intracellular levels of βAPP. The effect of treating the cells with tacrine did not depend upon the growing state of the cells as a similar effect was observed when the drug was added either during initial plating of the cells or after the attachment of the cells. The effect of tacrine was not affected by preincubating the cells with low serum in the culture medium. The treatment of cells with tacrine plus leupeptin reduced the secretion of sAPP in the medium to the same degree as did the treatment with tacrine alone, suggesting that the tacrine-mediated inhibition of sAPP release may not involve leupeptin-sensitive proteolytic pathways. The results suggest that the inhibitory effect of tacrine on sAPP secretion is not due to the proteolytic cleavage of the holoprotein in the medium.

AB - The senile plaque in Alzheimer's disease (AD) consists mainly of the amyloid β-peptide (Aβ) derived from a larger beta-amyloid precursor protein (βAPP). The majority of BAPP is processed by either a secretory or lysosomal/ endosomal pathway. Soluble derivatives of βAPP (sAPP) and Aβ generated by the proteolytic processing of full-length βAPP are normally secreted into the conditioned medium of cultured cells. Tacrine, a centrally active potent cholinesterase inhibitor that has been shown to improve cognitive functions in some patients with AD, inhibits the secretion of sAPP. Here we have investigated whether leupeptin, a lysosomal protease inhibitor, could influence this effect of tacrine. We analyzed levels of βAPP derivatives in cultured HeLa cells by immunoblotting cell lysates and conditioned media using the monoclonal antibody 22C11. Levels of sAPP normally present in conditioned media were severely reduced by treating cells with tacrine. The treatment of cells with tacrine resulted in a small decrease in the intracellular levels of βAPP. The effect of treating the cells with tacrine did not depend upon the growing state of the cells as a similar effect was observed when the drug was added either during initial plating of the cells or after the attachment of the cells. The effect of tacrine was not affected by preincubating the cells with low serum in the culture medium. The treatment of cells with tacrine plus leupeptin reduced the secretion of sAPP in the medium to the same degree as did the treatment with tacrine alone, suggesting that the tacrine-mediated inhibition of sAPP release may not involve leupeptin-sensitive proteolytic pathways. The results suggest that the inhibitory effect of tacrine on sAPP secretion is not due to the proteolytic cleavage of the holoprotein in the medium.

KW - Alzheimer's disease

KW - Amyloid precursor proteins

KW - Cholinergic agents

KW - Cholinesterase inhibitors

KW - Lysosomes

UR - http://www.scopus.com/inward/record.url?scp=0030729956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030729956&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(97)00868-0

DO - 10.1016/S0024-3205(97)00868-0

M3 - Article

C2 - 9366505

AN - SCOPUS:0030729956

VL - 61

SP - 1985

EP - 1992

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 20

ER -